Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology
Link
http://link.springer.com/content/pdf/10.1007/s00213-015-4047-2.pdf
Reference30 articles.
1. Amsterdam JD, Maislin G, Potter L (1994) Fluoxetine efficacy in treatment resistant depression. Prog Neuropsychopharmacol Biol Psychiatry 18(2):243–261
2. Amsterdam JD, Shults J (2005) MAOI efficacy and safety in advanced stage treatment-resistant depression: a retrospective study. J Affect Disord 89(1–3):183–188
3. Amsterdam JD, Williams D, Michelson D, Adler LA, Dunner DL, Nierenberg AA, Reimherr FW, Schatzberg AF (2009) Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder. Neuropsychobiology 59(4):227–233
4. Brown WA, Johnson MF, Chen MG (1992) Clinical features of depressed patients who do and do not improve with placebo. Psychiatry Res 41(3):203–214
5. Cohen J (1988) Statistical power analysis for the behavioral sciences. Mahwah, New Jersey, pp 283–286
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo;Nature Mental Health;2024-01-12
2. Bayesian analysis of real‐world data as evidence for drug approval: Remembering Sir Michael Rawlins;British Journal of Clinical Pharmacology;2023-07-17
3. Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis;BMJ;2022-08-02
4. Depression: why drugs and electricity are not the answer;Psychological Medicine;2022-02-01
5. Psychological Healing and Leveraging the Placebo Effect;Promoting Healing and Resilience in People with Cancer: A Nursing Perspective;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3